{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:49:25Z","timestamp":1792788565963,"version":"4.5.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T00:00:00Z","timestamp":1748649600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T00:00:00Z","timestamp":1748649600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"King Saud University, Riyadh, Saud Arabia","award":["RSPD2024R632"],"award-info":[{"award-number":["RSPD2024R632"]}],"id":[{"id":"https:\/\/ror.org\/02f81g417","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hereditas"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Thyroid cancer, characterized by significant genetic and epigenetic alterations, remains a critical focus of molecular oncology. This study investigates eight key genes (BRAF, EIF1 AX, FOXE1, KRAS, PDGFRA, PIK3 CA, PTEN, and TERT) that are deregulated in Hashimoto's Thyroiditis and their roles in thyroid cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Cell culture, nucleic acid extraction, RT-qPCR, bisulfite sequencing, and various in silico tools and databases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Expression analysis using RT-qPCR revealed significant (\n                      <jats:italic>p<\/jats:italic>\n                      -value &lt;\u20090.05) down-regulation of BRAF, EIF1 AX, FOXE1, KRAS, PDGFRA, PIK3 CA, PTEN, and TERT genes in thyroid cancer cell lines compared to controls, with ROC curves indicating high diagnostic accuracy (AUC 0.93\u20130.99). Bisulfite sequencing demonstrated increased promoter methylation across all eight genes in cancerous samples, suggesting epigenetic silencing as a regulatory mechanism. Validation through UALCAN, OncoDB, and HPA confirmed reduced gene and protein expression in additional thyroid cancer cohorts. Genetic alteration analysis via cBioPortal showed prevalent BRAF mutations, whereas other genes exhibited fewer alterations. Kaplan\u2013Meier survival analysis linked lower expression of BRAF and PIK3 CA to poorer overall survival. Correlation studies using TISIDB and TISCH2 databases highlighted associations between gene expression and immune modulation, revealing significant correlations with immune cell infiltration and diverse immune subtypes. Moreover, miRNA-mRNA network analysis identified hsa-mir- 628 -\u20095p as a critical regulator targeting these genes. The impact of BRAF overexpression on SW579 cells was assessed through various functional assays. Overexpression of BRAF resulted in reduced cell proliferation, colony formation, and wound healing, which may reflect context-dependent effects. While BRAF is typically oncogenic, its overexpression may lead to cellular stress or negative feedback mechanisms that impair these processes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This comprehensive analysis elucidates the complex regulatory landscape of these genes in thyroid cancer, emphasizing the significant role of epigenetic modifications and providing insights into potential diagnostic and therapeutic avenues.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41065-025-00429-0","type":"journal-article","created":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T07:36:10Z","timestamp":1748676970000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["RETRACTED ARTICLE: Deciphering the role of Hashimoto's Thyroiditis-related key genes in thyroid cancer via detailed in silico analysis followed by the experimental validation"],"prefix":"10.1186","volume":"162","author":[{"given":"Mostafa A.","family":"Abdel-Maksoud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taghreed N.","family":"Almana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeedah","family":"Almutair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulaziz","family":"Alamri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim A.","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Y.","family":"Zaky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wahidah H.","family":"Al-Qahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasir","family":"Hameed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,31]]},"reference":[{"issue":"2","key":"429_CR1","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s12020-022-03274-7","volume":"80","author":"J Huang","year":"2023","unstructured":"Huang J, Ngai CH, Deng Y, Pun CN, Lok V, Zhang L, et al. Incidence and mortality of thyroid cancer in 50 countries: a joinpoint regression analysis of global trends. Endocrine. 2023;80(2):355\u201365.","journal-title":"Endocrine"},{"key":"429_CR2","doi-asserted-by":"publisher","first-page":"04084","DOI":"10.7189\/jogh.14.04084","volume":"14","author":"S Hu","year":"2024","unstructured":"Hu S, Wu X, Jiang H. Trends and projections of the global burden of thyroid cancer from 1990 to 2030. J Global Health. 2024;14:04084.","journal-title":"J Global Health"},{"key":"429_CR3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cancergen.2024.06.002","volume":"286\u2013287","author":"D Sonkin","year":"2024","unstructured":"Sonkin D, Thomas A, Teicher BA. Cancer treatments: Past, present, and future. Cancer Genet. 2024;286\u2013287:18\u201324.","journal-title":"Cancer Genet"},{"issue":"1","key":"429_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ecl.2018.10.002","volume":"48","author":"CD Seib","year":"2019","unstructured":"Seib CD, Sosa JA. Evolving understanding of the epidemiology of thyroid cancer. Endocrinol Metab Clin. 2019;48(1):23\u201335.","journal-title":"Endocrinol Metab Clin"},{"issue":"4","key":"429_CR5","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S2213-8587(21)00027-9","volume":"9","author":"A Miranda-Filho","year":"2021","unstructured":"Miranda-Filho A, Lortet-Tieulent J, Bray F, Cao B, Franceschi S, Vaccarella S, et al. Thyroid cancer incidence trends by histology in 25 countries: a population-based study. Lancet Diabetes Endocrinol. 2021;9(4):225\u201334.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"429_CR6","doi-asserted-by":"publisher","first-page":"e3010","DOI":"10.1210\/clinem\/dgaa376","volume":"105","author":"D Bradley","year":"2020","unstructured":"Bradley D. Obesity, thyroid nodularity, and thyroid cancer: epiphenomenon or cause? J Clin Endocrinol Metab. 2020;105(8):e3010\u20132.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"429_CR7","doi-asserted-by":"publisher","first-page":"4185","DOI":"10.1007\/s00405-023-07992-0","volume":"280","author":"YC Hsu","year":"2023","unstructured":"Hsu YC, Cheng SYH, Chien MN, Cheng SP. Impact of social and economic factors on global thyroid cancer incidence and mortality. Eur Arch Oto Rhino Laryngol. 2023;280(9):4185\u201393.","journal-title":"Eur Arch Oto Rhino Laryngol"},{"key":"429_CR8","doi-asserted-by":"crossref","unstructured":"Health Commission Of The People's Republic Of China N. National guidelines for diagnosis and treatment of thyroid cancer 2022 in China (English version). Chin J Cancer Res. 2022;34(3):131\u201350.","DOI":"10.21147\/j.issn.1000-9604.2022.03.01"},{"issue":"6","key":"429_CR9","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1089\/thy.2014.0335","volume":"25","author":"SA Wells Jr","year":"2015","unstructured":"Wells SA Jr, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF, et al. Revised American thyroid association guidelines for the management of medullary thyroid carcinoma. Thyroid. 2015;25(6):567\u2013610.","journal-title":"Thyroid"},{"issue":"7","key":"429_CR10","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.3390\/ijerph16071185","volume":"16","author":"M Fiore","year":"2019","unstructured":"Fiore M, Oliveri Conti G, Caltabiano R, Buffone A, Zuccarello P, Cormaci L, et al. Role of emerging environmental risk factors in thyroid cancer: a brief review. Int J Environ Res Public Health. 2019;16(7):1185.","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"429_CR11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.62347\/TWOY1681","volume":"16","author":"MA Abdel-Maksoud","year":"2024","unstructured":"Abdel-Maksoud MA, Ullah S, Nadeem A, Shaikh A, Zia MK, Zakri AM, et al. Unlocking the diagnostic, prognostic roles, and immune implications of BAX gene expression in pan-cancer analysis. Am J Transl Res. 2024;16(1):63.","journal-title":"Am J Transl Res"},{"issue":"3","key":"429_CR12","doi-asserted-by":"publisher","first-page":"873","DOI":"10.62347\/NCPH5416","volume":"16","author":"L Huang","year":"2024","unstructured":"Huang L, Irshad S, Sultana U, Ali S, Jamil A, Zubair A, et al. Pan-cancer analysis of HS6ST2: associations with prognosis, tumor immunity, and drug resistance. Am J Transl Res. 2024;16(3):873.","journal-title":"Am J Transl Res"},{"issue":"1","key":"429_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/PAP.0000000000000380","volume":"30","author":"B Xu","year":"2023","unstructured":"Xu B, Ghossein RA. Advances in thyroid pathology: high grade follicular cell-derived thyroid carcinoma and anaplastic thyroid carcinoma. Adv Anat Pathol. 2023;30(1):3\u201310.","journal-title":"Adv Anat Pathol"},{"issue":"5\u20136","key":"429_CR14","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1080\/19396368.2022.2074325","volume":"68","author":"Y Gao","year":"2022","unstructured":"Gao Y, Wang C, Wang K, He C, Hu K, Liang M. The effects and molecular mechanism of heat stress on spermatogenesis and the mitigation measures. Syst Biol Reprod Med. 2022;68(5\u20136):331\u201347.","journal-title":"Syst Biol Reprod Med"},{"issue":"7","key":"429_CR15","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1089\/thy.2013.0588","volume":"24","author":"R Paparodis","year":"2014","unstructured":"Paparodis R, Imam S, Todorova-Koteva K, Staii A, Jaume JC. Hashimoto\u2019s thyroiditis pathology and risk for thyroid cancer. Thyroid. 2014;24(7):1107\u201314.","journal-title":"Thyroid"},{"issue":"10","key":"429_CR16","doi-asserted-by":"publisher","first-page":"102649","DOI":"10.1016\/j.autrev.2020.102649","volume":"19","author":"M Ralli","year":"2020","unstructured":"Ralli M, Angeletti D, Fiore M, D\u2019Aguanno V, Lambiase A, Artico M, et al. Hashimoto\u2019s thyroiditis: An update on pathogenic mechanisms, diagnostic protocols, therapeutic strategies, and potential malignant transformation. Autoimmun Rev. 2020;19(10):102649.","journal-title":"Autoimmun Rev"},{"key":"429_CR17","doi-asserted-by":"publisher","first-page":"266497","DOI":"10.3389\/fendo.2017.00092","volume":"8","author":"M Cellini","year":"2017","unstructured":"Cellini M, Santaguida MG, Virili C, Capriello S, Brusca N, Gargano L, et al. Hashimoto\u2019s thyroiditis and autoimmune gastritis. Front Endocrinol. 2017;8:266497.","journal-title":"Front Endocrinol"},{"issue":"16","key":"429_CR18","doi-asserted-by":"publisher","first-page":"5376","DOI":"10.7150\/jca.98723","volume":"15","author":"L Liang","year":"2024","unstructured":"Liang L, Liang X, Yu X, Xiang W. Bioinformatic analyses and integrated machine learning to predict prognosis and therapeutic response based on E3 ligase-related genes in colon cancer. J Cancer. 2024;15(16):5376.","journal-title":"J Cancer"},{"key":"429_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00277-024-06119-7","volume":"103","author":"T Bin","year":"2024","unstructured":"Bin T, Tang J, Lu B, Xu XJ, Lin C, Wang Y. Construction of AML prognostic model with CYP2E1 and GALNT12 biomarkers based on golgi-associated genes. Ann Hematol. 2024;103:1\u201318.","journal-title":"Ann Hematol"},{"issue":"7","key":"429_CR20","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.4103\/jcrt.jcrt_1902_21","volume":"19","author":"Y Hameed","year":"2023","unstructured":"Hameed Y. Decoding the significant diagnostic and prognostic importance of maternal embryonic leucine zipper kinase in human cancers through deep integrative analyses. J Cancer Res Ther. 2023;19(7):1852\u201364.","journal-title":"J Cancer Res Ther"},{"issue":"3","key":"429_CR21","doi-asserted-by":"publisher","first-page":"738","DOI":"10.62347\/YORR3755","volume":"16","author":"J Wang","year":"2024","unstructured":"Wang J, Gilani SF, Noor N, Ahmed MR, Munazir M, Zubair A, et al. Decoding the DSCC1 gene as a pan-cancer biomarker in human cancers via comprehensive multi-omics analyses. Am J Transl Res. 2024;16(3):738.","journal-title":"Am J Transl Res"},{"issue":"4","key":"429_CR22","first-page":"224","volume":"24","author":"S Ghatak","year":"2013","unstructured":"Ghatak S, Muthukumaran RB, Nachimuthu SK. A simple method of genomic DNA extraction from human samples for PCR-RFLP analysis. J Biomol Tech. 2013;24(4):224\u201331.","journal-title":"J Biomol Tech"},{"issue":"4","key":"429_CR23","doi-asserted-by":"publisher","first-page":"467","DOI":"10.2144\/000112401","volume":"42","author":"AB Hummon","year":"2007","unstructured":"Hummon AB, Lim SR, Difilippantonio MJ, Ried T. Isolation and solubilization of proteins after TRIzol extraction of RNA and DNA from patient material following prolonged storage. Biotechniques. 2007;42(4):467\u201370.","journal-title":"Biotechniques"},{"issue":"8","key":"429_CR24","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","volume":"19","author":"DS Chandrashekar","year":"2017","unstructured":"Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi B, et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017;19(8):649\u201358.","journal-title":"Neoplasia"},{"issue":"3","key":"429_CR25","doi-asserted-by":"publisher","first-page":"940","DOI":"10.62347\/QNNE5428","volume":"16","author":"M Luo","year":"2024","unstructured":"Luo M, Rehman A, Haque S, Izhar S, Perveen F, Haris M, et al. Thorough examination of the potential biological implications of the cuproptosis-related gene LIPT2 in the prognosis and immunotherapy in pan-cancer. Am J Transl Res. 2024;16(3):940.","journal-title":"Am J Transl Res"},{"issue":"1","key":"429_CR26","doi-asserted-by":"publisher","first-page":"bbac558","DOI":"10.1093\/bib\/bbac558","volume":"24","author":"CJ Liu","year":"2023","unstructured":"Liu CJ, Hu FF, Xie GY, Miao YR, Li XW, Zeng Y, et al. GSCA: an integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels. Brief Bioinform. 2023;24(1):bbac558.","journal-title":"Brief Bioinform"},{"issue":"1","key":"429_CR27","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/pro.3307","volume":"27","author":"PJ Thul","year":"2018","unstructured":"Thul PJ, Lindskog C. The human protein atlas: a spatial map of the human proteome. Protein Sci. 2018;27(1):233\u201344.","journal-title":"Protein Sci"},{"issue":"D1","key":"429_CR28","doi-asserted-by":"publisher","first-page":"D1334","DOI":"10.1093\/nar\/gkab970","volume":"50","author":"G Tang","year":"2022","unstructured":"Tang G, Cho M, Wang X. OncoDB: an interactive online database for analysis of gene expression and viral infection in cancer. Nucleic Acids Res. 2022;50(D1):D1334\u20139.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"429_CR29","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401\u20134.","journal-title":"Cancer Discov"},{"issue":"1","key":"429_CR30","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s41065-025-00369-9","volume":"162","author":"F Jiang","year":"2025","unstructured":"Jiang F, Ahmad S, Kanwal S, Hameed Y, Tang Q. Key wound healing genes as diagnostic biomarkers and therapeutic targets in uterine corpus endometrial carcinoma: an integrated in silico and in vitro study. Hereditas. 2025;162(1):5.","journal-title":"Hereditas"},{"issue":"3","key":"429_CR31","doi-asserted-by":"publisher","first-page":"bbac090","DOI":"10.1093\/bib\/bbac090","volume":"23","author":"X Cheng","year":"2022","unstructured":"Cheng X, Liu Y, Wang J, Chen Y, Robertson AG, Zhang X, et al. cSurvival: a web resource for biomarker interactions in cancer outcomes and in cell lines. Brief Bioinform. 2022;23(3):bbac090.","journal-title":"Brief Bioinform"},{"issue":"20","key":"429_CR32","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1093\/bioinformatics\/btz210","volume":"35","author":"B Ru","year":"2019","unstructured":"Ru B, Wong CN, Tong Y, Zhong JY, Zhong SSW, Wu WC, et al. TISIDB: an integrated repository portal for tumor-immune system interactions. Bioinformatics. 2019;35(20):4200\u20132.","journal-title":"Bioinformatics"},{"issue":"W1","key":"429_CR33","doi-asserted-by":"publisher","first-page":"W244","DOI":"10.1093\/nar\/gkaa467","volume":"48","author":"L Chang","year":"2020","unstructured":"Chang L, Zhou G, Soufan O, Xia J. miRNet 2.0: network-based visual analytics for miRNA functional analysis and systems biology. Nucleic Acids Res. 2020;48(W1):W244\u201351.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"429_CR34","doi-asserted-by":"publisher","first-page":"D900","DOI":"10.1093\/nar\/gky939","volume":"47","author":"H Yuan","year":"2019","unstructured":"Yuan H, Yan M, Zhang G, Liu W, Deng C, Liao G, et al. CancerSEA: a cancer single-cell state atlas. Nucleic Acids Res. 2019;47(D1):D900\u20138.","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"429_CR35","doi-asserted-by":"publisher","first-page":"W216","DOI":"10.1093\/nar\/gkac194","volume":"50","author":"BT Sherman","year":"2022","unstructured":"Sherman BT, Hao M, Qiu J, Jiao X, Baseler MW, Lane HC, et al. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 2022;50(W1):W216\u201321.","journal-title":"Nucleic Acids Res"},{"key":"429_CR36","doi-asserted-by":"publisher","first-page":"707233","DOI":"10.3389\/fendo.2021.707233","volume":"12","author":"Y Li","year":"2021","unstructured":"Li Y, Piao J, Li M. Secular trends in the epidemiologic patterns of thyroid cancer in China over three decades: an updated systematic analysis of global burden of disease study 2019 data. Front Endocrinol. 2021;12:707233.","journal-title":"Front Endocrinol"},{"issue":"6","key":"429_CR37","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1210\/clinem\/dgaa121","volume":"105","author":"KL Yan","year":"2020","unstructured":"Yan KL, Li S, Tseng C-H, Kim J, Nguyen DT, Dawood NB, et al. Rising incidence and incidence-based mortality of thyroid cancer in California, 2000\u20132017. J Clin Endocrinol Metab. 2020;105(6):1770\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"429_CR38","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s40364-024-00687-6","volume":"12","author":"D-F Cao","year":"2024","unstructured":"Cao D-F, Zhou X-Y, Guo Q, Xiang M-Y, Bao M-H, He B-S, et al. Unveiling the role of histone deacetylases in neurological diseases: focus on epilepsy. Biomarker Res. 2024;12(1):142.","journal-title":"Biomarker Res"},{"issue":"17","key":"429_CR39","doi-asserted-by":"publisher","first-page":"21546","DOI":"10.1021\/acsami.4c00793","volume":"16","author":"Y Chen","year":"2024","unstructured":"Chen Y, Deng Y, Li Y, Qin Y, Zhou Z, Yang H, et al. Oxygen-independent radiodynamic therapy: radiation-boosted chemodynamics for reprogramming the tumor immune environment and enhancing antitumor immune response. ACS Appl Mater Interfaces. 2024;16(17):21546\u201356.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"4","key":"429_CR40","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s10637-024-01452-0","volume":"42","author":"P Luo","year":"2024","unstructured":"Luo P, Guo Y, He Y, Wang C. Clinical characteristics, treatment and outcome of pembrolizumab-induced acute pancreatitis. Invest New Drugs. 2024;42(4):369\u201375.","journal-title":"Invest New Drugs"},{"issue":"10","key":"429_CR41","doi-asserted-by":"publisher","first-page":"7905","DOI":"10.1007\/s00210-024-03135-2","volume":"397","author":"W Fang","year":"2024","unstructured":"Fang W, Sun W, Fang W, Zhang J, Wang C. Clinical features, treatment, and outcome of pembrolizumab induced cholangitis. Naunyn Schmiedebergs Arch Pharmacol. 2024;397(10):7905\u201312.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"429_CR42","doi-asserted-by":"crossref","unstructured":"Wang Y, Xu Y, Song J, Liu X, Liu S, Yang N, et al. Tumor cell-targeting and tumor microenvironment\u2013responsive nanoplatforms for the multimodal imaging-guided photodynamic\/photothermal\/chemodynamic treatment of cervical cancer. International journal of nanomedicine. 2024:5837\u201358.","DOI":"10.2147\/IJN.S466042"},{"key":"429_CR43","doi-asserted-by":"publisher","first-page":"119513","DOI":"10.1016\/j.ijpharm.2020.119513","volume":"585","author":"Y Nie","year":"2020","unstructured":"Nie Y, Li D, Peng Y, Wang S, Hu S, Liu M, et al. Metal organic framework coated MnO2 nanosheets delivering doxorubicin and self-activated DNAzyme for chemo-gene combinatorial treatment of cancer. Int J Pharm. 2020;585:119513.","journal-title":"Int J Pharm"},{"issue":"3","key":"429_CR44","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.3390\/ijms21031102","volume":"21","author":"S Lee","year":"2020","unstructured":"Lee S, Rauch J, Kolch W. Targeting MAPK signaling in cancer: mechanisms of drug resistance and sensitivity. Int J Mol Sci. 2020;21(3):1102.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"429_CR45","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3390\/biom14050585","volume":"14","author":"C Lliberos","year":"2024","unstructured":"Lliberos C, Richardson G, Papa A. Oncogenic pathways and targeted therapies in ovarian cancer. Biomolecules. 2024;14(5):585.","journal-title":"Biomolecules"},{"issue":"3\u20134","key":"429_CR46","doi-asserted-by":"publisher","first-page":"CBM-240119","DOI":"10.3233\/CBM-240119","volume":"41","author":"AM Rasteh","year":"2024","unstructured":"Rasteh AM, Liu H, Wang P. Pan-cancer genetic profiles of mitotic DNA integrity checkpoint protein kinases. Cancer Biomarkers. 2024;41(3\u20134):CBM-240119.","journal-title":"Cancer Biomarkers"},{"issue":"7","key":"429_CR47","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.3390\/cancers12071984","volume":"12","author":"Q Chen","year":"2020","unstructured":"Chen Q, Yang B, Nass N, Schatz C, Haybaeck J. Impact of eukaryotic translation initiation factors on breast cancer: still much to investigate. Cancers. 2020;12(7):1984.","journal-title":"Cancers"},{"issue":"2","key":"429_CR48","doi-asserted-by":"publisher","first-page":"215","DOI":"10.2217\/epi-2018-0176","volume":"11","author":"K Grafanaki","year":"2019","unstructured":"Grafanaki K, Anastasakis D, Kyriakopoulos G, Skeparnias I, Georgiou S, Stathopoulos C. Translation regulation in skin cancer from a tRNA point of view. Epigenomics. 2019;11(2):215\u201345.","journal-title":"Epigenomics"},{"key":"429_CR49","unstructured":"Rurale G. Zebrafish as model system to study the role of the glis3 transcription factor in the pathogenesis of congenital hypothyroidism. 2019."},{"key":"429_CR50","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.ijbiomac.2022.01.113","volume":"202","author":"X Zou","year":"2022","unstructured":"Zou X, Tang XY, Qu ZY, Sun ZW, Ji CF, Li YJ, et al. Targeting the PDGF\/PDGFR signaling pathway for cancer therapy: a review. Int J Biol Macromol. 2022;202:539\u201357.","journal-title":"Int J Biol Macromol"},{"issue":"2","key":"429_CR51","first-page":"555","volume":"38","author":"Y Dong","year":"2011","unstructured":"Dong Y, Jia L, Wang X, Tan X, Xu J, Deng Z, et al. Selective inhibition of PDGFR by imatinib elicits the sustained activation of ERK and downstream receptor signaling in malignant glioma cells. Int J Oncol. 2011;38(2):555\u201369.","journal-title":"Int J Oncol"},{"issue":"3","key":"429_CR52","first-page":"1439","volume":"41","author":"M Hu","year":"2019","unstructured":"Hu M, Zhu S, Xiong S, Xue X, Zhou X. MicroRNAs and the PTEN\/PI3K\/Akt pathway in gastric cancer. Oncol Rep. 2019;41(3):1439\u201354.","journal-title":"Oncol Rep"},{"issue":"6","key":"429_CR53","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.3390\/cancers13061213","volume":"13","author":"F Dogan","year":"2021","unstructured":"Dogan F, Forsyth NR. Telomerase regulation: a role for epigenetics. Cancers. 2021;13(6):1213.","journal-title":"Cancers"},{"issue":"8","key":"429_CR54","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1158\/0008-5472.CAN-22-2236","volume":"83","author":"J Gallon","year":"2023","unstructured":"Gallon J, Rodriguez-Calero A, Benjak A, Akhoundova D, Maletti S, Amstutz U, et al. DNA methylation landscapes of prostate cancer brain metastasis are shaped by early driver genetic alterations. Can Res. 2023;83(8):1203\u201313.","journal-title":"Can Res"},{"issue":"1","key":"429_CR55","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1530\/ERC-14-0439","volume":"22","author":"A Lakshmanan","year":"2015","unstructured":"Lakshmanan A, Wojcicka A, Kotlarek M, Zhang X, Jazdzewski K, Jhiang SM. microRNA-339-5p modulates Na+\/I\u2212 symporter-mediated radioiodide uptake. Endocr Relat Cancer. 2015;22(1):11\u201321.","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"429_CR56","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3233\/CBM-182265","volume":"25","author":"A Botezatu","year":"2019","unstructured":"Botezatu A, Iancu IV, Plesa A, Manda D, Popa O, Bostan M, et al. Methylation of tumour suppressor genes associated with thyroid cancer. Cancer Biomark. 2019;25(1):53\u201365.","journal-title":"Cancer Biomark"},{"issue":"12","key":"429_CR57","first-page":"2461","volume":"50","author":"S Sheikholeslami","year":"2021","unstructured":"Sheikholeslami S, Zarif-Yeganeh M, Farashi S, Azizi F, Kia SK, Teimoori-Toolabi L, et al. Promoter methylation of tumor suppressors in thyroid carcinoma: a systematic review. Iran J Public Health. 2021;50(12):2461\u201372.","journal-title":"Iran J Public Health"},{"issue":"3","key":"429_CR58","doi-asserted-by":"publisher","first-page":"273","DOI":"10.21053\/ceo.2022.00206","volume":"15","author":"JW Yi","year":"2022","unstructured":"Yi JW, Ha SY, Jee HG, Kim K, Kim SJ, Chai YJ, et al. Induction of the BRAFV600E mutation in thyroid cells leads to frequent hypermethylation. Clin Exp Otorhinolaryngol. 2022;15(3):273\u201382.","journal-title":"Clin Exp Otorhinolaryngol"},{"issue":"12","key":"429_CR59","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1038\/aps.2013.163","volume":"34","author":"WF Wang","year":"2013","unstructured":"Wang WF, Xie Y, Zhou ZH, Qin ZH, Wu JC, He JK. PIK3CA hypomethylation plays a key role in activation of the PI3K\/AKT pathway in esophageal cancer in Chinese patients. Acta Pharmacol Sin. 2013;34(12):1560\u20137.","journal-title":"Acta Pharmacol Sin"},{"issue":"10","key":"429_CR60","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1002\/1878-0261.12786","volume":"14","author":"TJ Rowland","year":"2020","unstructured":"Rowland TJ, Bonham AJ, Cech TR. Allele-specific proximal promoter hypomethylation of the telomerase reverse transcriptase gene (TERT) associates with TERT expression in multiple cancers. Mol Oncol. 2020;14(10):2358\u201374.","journal-title":"Mol Oncol"},{"issue":"1","key":"429_CR61","doi-asserted-by":"publisher","first-page":"10149","DOI":"10.1038\/s41598-020-66797-x","volume":"10","author":"BY Tew","year":"2020","unstructured":"Tew BY, Durand JK, Bryant KL, Hayes TK, Peng S, Tran NL, et al. Genome-wide DNA methylation analysis of KRAS mutant cell lines. Sci Rep. 2020;10(1):10149.","journal-title":"Sci Rep"},{"issue":"4","key":"429_CR62","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.3390\/ijms22041726","volume":"22","author":"C Romei","year":"2021","unstructured":"Romei C, Elisei R. A narrative review of genetic alterations in primary thyroid epithelial cancer. Int J Mol Sci. 2021;22(4):1726.","journal-title":"Int J Mol Sci"},{"key":"429_CR63","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s12672-014-0207-9","volume":"6","author":"M Cabanillas","year":"2015","unstructured":"Cabanillas M, Patel A, Danysh B, Dadu R, Kopetz S, Falchook G. BRAF inhibitors: experience in thyroid cancer and general review of toxicity. Hormones and Cancer. 2015;6:21\u201336.","journal-title":"Hormones and Cancer"},{"issue":"5","key":"429_CR64","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s40265-018-0884-8","volume":"78","author":"JN Sanchez","year":"2018","unstructured":"Sanchez JN, Wang T, Cohen MS. BRAF and MEK inhibitors: use and resistance in BRAF-mutated cancers. Drugs. 2018;78(5):549\u201366.","journal-title":"Drugs"},{"issue":"11","key":"429_CR65","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.31557\/APJCP.2022.23.11.3617","volume":"23","author":"WA Harahap","year":"2022","unstructured":"Harahap WA, Tofrizal T, Oktahermoniza O. Relationship between the expression of BRAF V600E and Ki-67 with the recurrence of well-differentiated thyroid cancer. Asian Pac J Cancer Prev. 2022;23(11):3617\u201322.","journal-title":"Asian Pac J Cancer Prev"},{"key":"429_CR66","doi-asserted-by":"crossref","unstructured":"Liotti F, Prevete N, Vecchio G, Melillo RM. Recent advances in understanding immune phenotypes of thyroid carcinomas: prognostication and emerging therapies. F1000Res. 1000;28(8)","DOI":"10.12688\/f1000research.16677.1"},{"issue":"3","key":"429_CR67","first-page":"1481","volume":"21","author":"F Guo","year":"2020","unstructured":"Guo F, Xue J. MicroRNA-628-5p inhibits cell proliferation and induces apoptosis in colorectal cancer through downregulating CCND1 expression levels. Mol Med Rep. 2020;21(3):1481\u201390.","journal-title":"Mol Med Rep"}],"updated-by":[{"DOI":"10.1186\/s41065-026-00754-y","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000}}],"container-title":["Hereditas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00429-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41065-025-00429-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00429-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:02:17Z","timestamp":1791928937000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41065-025-00429-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,31]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["429"],"URL":"https:\/\/doi.org\/10.1186\/s41065-025-00429-0","relation":{},"ISSN":["1601-5223"],"issn-type":[{"value":"1601-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,31]]},"assertion":[{"value":"17 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been retracted. Please see the Retraction Notice for more detail:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s41065-026-00754-y","URL":"https:\/\/doi.org\/10.1186\/s41065-026-00754-y","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"91"}}